Comparison of the activity of alclofenac and of acetylsalicylic acid in rheumatoid arthritis; a double blind study and cross permutation
Fostiropoulos, G.
Therapie 29(6): 933-939
1974
ISSN/ISBN: 0040-5957 PMID: 4618390 Document Number: 74782
Document emailed within 1 workday
Related Documents
Van Hoek, J. 1970: Double-blind comparison between 4-allyloxy-3-chlorophenylacetic acid (alclofenac) and phenylbutazone in osteoarthritis Current Therapeutic Research 12(9): 551-555Vojtisek, O.; Kanková, D.; Pavelka, K.; Hándlová, D. 1975: Comparison of the effects of niflumic acid and aloxiprin in patients with progressive chronic rheumatoid arthritis in a double blind trial Arzneimittel-Forschung 25(8): 1308-1311
Johnsen, A.K.; Schiff, M.H.; Mease, P.J.; Moreland, L.W.; Maier, A.L.; Coblyn, J.S.; Helfgott, S.M.; Leff, J.A.; Weinblatt, M.E. 2006: Comparison of 2 doses of etanercept (50 vs 100 mg) in active rheumatoid arthritis: a randomized double blind study Journal of Rheumatology 33(4): 659-664
Dornan, J.; Reynolds, W.J. 1974: Comparison of ibuprofen and acetylsalicylic acid in the treatment of rheumatoid arthritis Canadian Medical Association Journal 110(12): 1370-1372
Van der Laan, W.H.; Ronday, H.K.; TeKoppele, J.M.; Breedveld, F.C.; Huizinga, T.W.; Verheijen, J.H. 2003: No therapeutic effect of plasmin antagonist tranexamic acid in rheumatoid arthritis. a double-blind placebo-controlled pilot study Clinical and Experimental Rheumatology 21(3): 359-362
Pothmann, R. 1987: Prevention of migraine with flunarizine and acetylsalicylic acid. A double-blind study Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 135(9): 646-649
Domljan, Z.; Durrigl, T. 1983: Double-blind crossover comparison of piroxicam and indomethacin in rheumatoid arthritis European Journal of Rheumatology and Inflammation 6(3): 291-296
Desai, M.M.; Shetty, R.N. 1977: Double-blind crossover comparison of naproxen and indomethacin in rheumatoid arthritis Journal of the Association of Physicians of India 25(10): 703-707
Bröll, H. 1981: Long-term, double-blind, between patients comparison of indoprofen and indomethacin in rheumatoid arthritis European Journal of Rheumatology and Inflammation 4(1): 126-134
Putz, P.; Buyse, H.; Delvaux, D.; Kutnowski, M.; Demulder, A.; Dumont, N.; Lavenne, E.; Claes, R.; Rosillon, D. 1991: Triflusal versus acetylsalicylic acid: a double-blind study for the prophylaxis of deep vein thrombosis after hip surgery Acta Chirurgica Belgica 91(6): 269-276
Müller, P.; Dammann, H.G.; Bergdolt, H.; Simon, B. 1991: Protection from gastroduodenal adverse effects of acetylsalicylic acid with ranitidine. An endoscopic controlled double-blind study of healthy subjects Arzneimittel-Forschung 41(6): 638-639
Faarvang, K.L.; Nielsen, G.L.; Thomsen, B.S.; Teglbjaerg, K.L.; Hansen, T.M.; Lervang, H.H.; Schmidt, E.B.; Dyerberg, J.; Ernst, E. 1994: Fish oils and rheumatoid arthritis. a randomized and double-blind study Ugeskrift for Laeger 156(23): 3495-3498
Sigidin, I.A.; Murav'ev, I.V.; Sidel'nikova, S.M.; Taletene, I.P. 1983: Controlled (double blind) study of various regimens of levamisole administration in rheumatoid arthritis Terapevticheskii Arkhiv 55(9): 90-94
Shiokawa, Y.; Horiuchi, Y.; Mizushima, Y.; Kageyama, T.; Shichikawa, K.; Ofuji, T.; Honma, M.; Yoshizawa, H.; Abe, C.; Ogawa, N. 1984: A multicenter double-blind controlled study of lobenzarit, a novel immunomodulator, in rheumatoid arthritis Journal of Rheumatology 11(5): 615-623
Caldwell, J.R.; Germain, B.F.; Lourie, S.H.; McLaughlin, G.E.; Poiley, J.E.; Vreede, P.D.; Wilson, C.H. 1988: Ketoprofen versus indomethacin in patients with rheumatoid arthritis: a multicenter double blind comparative study Journal of Rheumatology 15(10): 1476-1479
Barnard-Jones, K.; Davies, R.W.; Lalla, O.; Mann, P.G.; Welch, R.B. 1986: Mefenamic acid versus ibuprofen in osteoarthritis--a double-blind cross-over study British Journal of Clinical Practice 40(12): 528-531
Dougados, M.; Listrat, V.; Duchesne, L.; Amor, B. 1992: Comparative efficacy of ketoprofen related to the route of administration (intramuscular or per os). a double-blind study versus placebo in rheumatoid arthritis Revue du Rhumatisme et des Maladies Osteo-Articulaires 59(11): 769-773
Kondo, H.; Abe, T.; Hashimoto, H.; Uchida, S.; Irimajiri, S.; Hara, M.; Sugawara, S. 2004: Efficacy and safety of tacrolimus (FK506) in treatment of rheumatoid arthritis: a randomized, double blind, placebo controlled dose-finding study Journal of Rheumatology 31(2): 243-251
Pavelka, K.; Vojtisek, O.; Bremová, A.; Kauková, D.; Hándlová, D. 1976: A new pyrazolidine derivative - benetazone spofa - in short- and medium-term treatment of rheumatoid arthritis. (Double-blind comparative study with phenylbutazone) International Journal of Clinical Pharmacology and Biopharmacy 14(1): 20-28
Kluthe, R.; Vogt, A.; Batsford, S. 1982: Double blind study of the influence of aristolochic acid on granulocyte phagocytic activity Arzneimittel-Forschung 32(4): 443-445